Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:06 pm
Purchase
13GCaribou Biosciences, Inc.
CRBU
PFM Health Sciences LP4,459,783
7.3%
367,474increase
(+8.98%)
View
2023-02-09
08:14 am
Sale
13GCaribou Biosciences, Inc.
CRBU
FMR LLC1,443,046
2.365%
-1,880,238decrease
(-56.58%)
View
2023-02-03
2:18 pm
Purchase
13GCaribou Biosciences, Inc.
CRBU
STATE STREET CORP
STT
3,198,893
5.24%
3,198,893increase
(New Position)
View
2023-02-03
12:10 pm
Purchase
13GCaribou Biosciences, Inc.
CRBU
BlackRock Inc.
BLK
4,722,083
7.7%
4,722,083increase
(New Position)
View
2022-06-01
5:23 pm
Sale
13GCaribou Biosciences, Inc.
CRBU
DUPONT E I DE NEMOURS & CO
DD
2,058,000
3.39%
-1,093,311decrease
(-34.69%)
View
2022-03-01
4:45 pm
Purchase
13GCaribou Biosciences, Inc.
CRBU
DUPONT E I DE NEMOURS & CO
DD
3,151,311
5.24%
3,151,311increase
(New Position)
View
2022-02-14
12:35 pm
Unchanged
13GCaribou Biosciences, Inc.
CRBU
PFM Health Sciences LP4,092,309
6.8%
0
(Unchanged)
View
2022-02-11
1:04 pm
Purchase
13GCaribou Biosciences, Inc.
CRBU
FARALLON CAPITAL MANAGEMENT LLC2,963,448
4.9%
2,963,448increase
(New Position)
View
2022-02-04
09:00 am
Purchase
13DCaribou Biosciences, Inc.
CRBU
Haurwitz Rachel E.3,621,319
6%
3,621,319increase
(New Position)
View
2021-08-06
5:04 pm
Purchase
13GCaribou Biosciences, Inc.
CRBU
PFM Health Sciences LP4,092,309
7.2%
4,092,309increase
(New Position)
View
2021-08-03
5:29 pm
Purchase
13GCaribou Biosciences, Inc.
CRBU
Farallon Capital Partners L.P.3,356,969
5.9%
3,356,969increase
(New Position)
View
2021-07-29
2:54 pm
Purchase
13GCaribou Biosciences, Inc.
CRBU
FMR LLC3,323,284
5.86%
3,323,284increase
(New Position)
View
2019-03-25
2:19 pm
Sale
13GIntellia Therapeutics, Inc.
NTLA
Caribou Biosciences Inc.
CRBU
1,807,841
4%
-699,404decrease
(-27.90%)
View
2019-01-16
5:29 pm
Sale
13GIntellia Therapeutics, Inc.
NTLA
Caribou Biosciences Inc.
CRBU
2,507,245
5.8%
-2,037,755decrease
(-44.84%)
View